LPL Financial LLC Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

LPL Financial LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 31.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 419,597 shares of the financial services provider’s stock after selling 192,858 shares during the period. LPL Financial LLC owned approximately 0.90% of iShares Biotechnology ETF worth $55,475,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of IBB. Kingsview Wealth Management LLC grew its position in shares of iShares Biotechnology ETF by 14.1% during the third quarter. Kingsview Wealth Management LLC now owns 3,543 shares of the financial services provider’s stock worth $516,000 after buying an additional 438 shares in the last quarter. Daiwa Securities Group Inc. lifted its stake in iShares Biotechnology ETF by 12.0% in the third quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock worth $150,000 after acquiring an additional 110 shares during the last quarter. FMR LLC grew its holdings in iShares Biotechnology ETF by 19.2% during the 3rd quarter. FMR LLC now owns 14,450 shares of the financial services provider’s stock worth $2,104,000 after acquiring an additional 2,332 shares in the last quarter. Townsquare Capital LLC increased its position in shares of iShares Biotechnology ETF by 10.1% in the 3rd quarter. Townsquare Capital LLC now owns 1,683 shares of the financial services provider’s stock valued at $245,000 after purchasing an additional 154 shares during the last quarter. Finally, CreativeOne Wealth LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $392,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.3 %

Shares of IBB stock opened at $131.58 on Friday. The company has a market cap of $6.22 billion, a P/E ratio of 27.83 and a beta of 0.84. The firm has a fifty day moving average price of $136.21 and a 200 day moving average price of $139.06. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were issued a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.